Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

3 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 7, 2023 GPCR P 1,500 $15.00 $22,500 1,500 Direct · Acquired 84.5% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 15, 2024 GPCR Stock Option (right to buy) Ordinary Shares [F3] (65,352) · March 14, 2034 65,352 Acquired
March 15, 2024 GPCR Stock Option (right to buy) Ordinary Shares (65,352) $35.25 March 14, 2034 65,352 Acquired
Feb. 7, 2023 GPCR American Depositary Shares Ordinary Shares (4,500) · · 1,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Feb. 2, 2023 GPCR Stock option (right to buy)→ Ordinary Shares (581,610) 581,610 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

GPCR

M.D., Ph.D. Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $466,375 · · · $149,499 · $12,500 $628,374

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.